Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
Irritable bowel syndrome (IBS) is the most common functional bowel disorder worldwide and is associated with visceral hypersensitivity, gut motility, immunomodulation, gut microbiota alterations, and dysfunction of the brain-gut axis; however, its pathophysiology remains poorly understood. Gut micro...
Main Authors: | Lin Xiao, Qin Liu, Mei Luo, Lishou Xiong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2021.729346/full |
Similar Items
-
The gut virome in Irritable Bowel Syndrome differs from that of controls
by: S. Coughlan, et al.
Published: (2021-01-01) -
Characteristics of the gut microbiota and the content of short-chain fatty acids in patients with irritable bowel syndrome
by: Yu.M. Stepanov, et al.
Published: (2019-09-01) -
Component-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B patients
by: Xiao Wei, et al.
Published: (2016-11-01) -
Gut microbiota was modulated by moxibustion stimulation in rats with irritable bowel syndrome
by: Xiaomei Wang, et al.
Published: (2018-12-01) -
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease
by: Edda Russo, et al.
Published: (2019-11-01)